CIK 0001159036 · Large accelerated filer
HALOZYME THERAPEUTICS, INC.
Sign in to watch- Ticker
- HALO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880488686
- Phone
- (858) 794-8889
- Business address
- 12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
- Former names
- HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $19,884,955
- in 5 filings, $19.9M under 10b5-1 plans
Net −$19,884,955. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-16 | Torley Helen PRESIDENT AND CEO | Shares withheld for taxes | −38,668 | $58.29 | $2.3M | 705,880 |
| 2025-02-16 | Torley Helen PRESIDENT AND CEO | Option exercise | +21,009 | 726,889 | ||
| 2025-02-16 | Torley Helen PRESIDENT AND CEO | Shares withheld for taxes | −11,313 | $58.29 | $659K | 715,576 |
| 2025-02-16 | Torley Helen PRESIDENT AND CEO | Option exercise | +16,875 | 732,451 | ||
| 2025-02-16 | Torley Helen PRESIDENT AND CEO | Shares withheld for taxes | −9,087 | $58.29 | $530K | 723,364 |
| 2025-02-16 | Torley Helen PRESIDENT AND CEO | Option exercise · Performance Stock Units | −71,810 | 0 | ||
| 2025-02-16 | Torley Helen PRESIDENT AND CEO | Option exercise · Restricted Stock Units | −21,009 | 21,009 | ||
| 2025-02-16 | Torley Helen PRESIDENT AND CEO | Option exercise · Restricted Stock Units | −16,875 | 33,749 | ||
| 2025-02-15 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Option exercise | +3,386 | 177,142 | ||
| 2025-02-15 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Shares withheld for taxes | −1,304 | $58.29 | $76K | 175,838 |
| 2025-02-15 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Option exercise · Restricted Stock Units | −3,386 | 0 | ||
| 2025-02-15 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | Option exercise | +1,254 | 16,734 | ||
| 2025-02-15 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −741 | $58.29 | $43K | 15,993 |
| 2025-02-15 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Units | −1,254 | 0 | ||
| 2025-02-15 | Torley Helen PRESIDENT AND CEO | Option exercise | +13,092 | 679,836 | ||
| 2025-02-15 | Torley Helen PRESIDENT AND CEO | Shares withheld for taxes | −7,098 | $58.29 | $414K | 672,738 |
| 2025-02-15 | Torley Helen PRESIDENT AND CEO | Option exercise · Restricted Stock Units | −13,092 | 0 | ||
| 2025-02-12 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Grant or award · Performance Stock Units | +7,262 | 20,891 | ||
| 2025-02-12 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Grant or award · Performance Stock Units | +4,177 | 6,547 | ||
| 2025-02-12 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Grant or award · Performance Stock Unit | +4,921 | 4,921 |
Page 22 of 26 · 513 trades